2989 related articles for article (PubMed ID: 6662722)
1. [Pregnancy and ovulation inhibitors as risk factors in malignant melanoma].
Zaun H
Hautarzt; 1983 Dec; 34(12):593-5. PubMed ID: 6662722
[TBL] [Abstract][Full Text] [Related]
2. [Pregnancy, hormone preparations and malignant melanoma].
Garbe C
Hautarzt; 1993 Jun; 44(6):347-52. PubMed ID: 8335457
[TBL] [Abstract][Full Text] [Related]
3. Do hormones influence melanoma? Facts and controversies.
Gupta A; Driscoll MS
Clin Dermatol; 2010; 28(3):287-92. PubMed ID: 20541681
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
Holly EA; Weiss NS; Liff JM
J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
[TBL] [Abstract][Full Text] [Related]
5. [Melanoma, pregnancy and oral contraception].
Veen G; Rampen FH; Lammes FB
Ned Tijdschr Geneeskd; 1983 Oct; 127(41):1865-8. PubMed ID: 6633738
[No Abstract] [Full Text] [Related]
6. [Cutaneous effects in hormonal contraception].
Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
[TBL] [Abstract][Full Text] [Related]
7. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
Holman CD; Armstrong BK; Heenan PJ
Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
10. [Contraception after heart transplantation].
Spina V; Aleandri V; Salvi M
Minerva Ginecol; 1998 Dec; 50(12):539-43. PubMed ID: 10069168
[TBL] [Abstract][Full Text] [Related]
11. [Advantages and risks of hormonal contraception].
Mall-Haefeli M
Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860
[TBL] [Abstract][Full Text] [Related]
12. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
Rosenberg MJ; Waugh MS; Long S
J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
[TBL] [Abstract][Full Text] [Related]
13. [Risks and perspectives of steroid contraceptives].
Presl J
Cesk Gynekol; 1981 Feb; 46(1):50-8. PubMed ID: 7273182
[TBL] [Abstract][Full Text] [Related]
14. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
15. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues.
Lens M; Bataille V
Cancer Causes Control; 2008 Jun; 19(5):437-42. PubMed ID: 18197460
[TBL] [Abstract][Full Text] [Related]
16. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect].
Hecht Y
Contracept Fertil Sex (Paris); 1991 May; 19(5):403-8. PubMed ID: 12316961
[TBL] [Abstract][Full Text] [Related]
18. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
19. [Contraception and hepatogastroenterology].
Grimaud JC; Bourliere M
Fertil Contracept Sex; 1989 May; 17(5):407-13. PubMed ID: 12316076
[TBL] [Abstract][Full Text] [Related]
20. [The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
Villatte-cathelineau B
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):147-52. PubMed ID: 12280201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
